Vivendi SE (OTCMKTS:VIVHY – Get Rating) was the recipient of a large growth in short interest in August. As of August 31st, there was short interest totalling 173,800 shares, a growth of 12,314.3% from the August 15th total of 1,400 shares. Based on an average daily volume of 373,800 shares, the short-interest ratio is currently 0.5 days.
Vivendi Trading Down 2.5 %
Shares of VIVHY stock opened at $8.45 on Thursday. The stock has a fifty day simple moving average of $9.34 and a two-hundred day simple moving average of $11.03. The company has a current ratio of 1.22, a quick ratio of 1.19 and a debt-to-equity ratio of 0.18. Vivendi has a 52-week low of $8.38 and a 52-week high of $14.23.
Get
Vivendi alerts:
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft reduced their price objective on Vivendi from €14.00 ($14.29) to €13.00 ($13.27) and set a "buy" rating for the company in a research note on Tuesday, July 26th. Morgan Stanley reduced their price objective on Vivendi from €13.40 ($13.67) to €12.00 ($12.24) and set an "overweight" rating for the company in a research note on Wednesday, July 20th. Finally, UBS Group reduced their price objective on Vivendi from €15.50 ($15.82) to €15.10 ($15.41) in a research note on Monday, August 1st. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $13.13.
About Vivendi
(Get Rating)
Vivendi SE operates as a entertainment, media, and communication company in France, the rest of Europe, the Americas, Asia/Oceania, and Africa. It operates through Canal+ Group, Havas Group, Editis, Prisma Media, Gameloft, Vivendi Village, Corporate, and New Initiative segments. The Canal+ Group segment publishes and distributes premium and thematic pay-TV and free-to-air channels; and produces, sells, and distributes movies and TV series.
Featured Stories
- Get a free copy of the StockNews.com research report on Vivendi (VIVHY)
- Is This Medical Gear Maker Ready To Continue Its Rally?
- The Five (5) Hottest Stocks To Watch Ahead Of Q3 Earnings
- Has Take-Two Interactive Devolved into a One-Trick Pony?
- Can Health Drink Maker Celsius Outrun Its Monster Rival?
- Is Lyft Going To Make It As Acquisition Rumors Swirl?
Receive News & Ratings for Vivendi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivendi and related companies with MarketBeat.com's FREE daily email newsletter.
